A Review of Classification of Emerging Excipients in Parenteral Medications

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2003, Volume 27, Issue 3

As parenteral drug delivery becomes more complex and sophisticated, excipients that can facilitate drug (or gene) delivery to specific therapeutic targets will be required. An overwhelming majority of these excipients are derived from natural sources.

Related Content:

ManufacturingExcipientsDevelopmentParenteralsDosage FormsManufacturing, Parenterals and InjectablesManufacturing, Drug ProductsPharmaceutical Technology-03-02-2003
Increasing mRNA Product Stability with Lyophilization
Bristol Myers Squibb to Access Cellares' Cell Therapy Manufacturing Platform in New $380 Million CAR-T Cell Therapy Deal
INTERPHEX 2024: Implementing Contamination Control Strategies in Cell and Gene Therapy Facilities